| P50 | author | Stuart Watson | Q56847475 |
| | Peter S Talbot | Q59094293 |
| | Hamish McAllister-Williams | Q60461332 |
| P2093 | author name string | Peter M Haddad | |
| | Ibrahim Jawad | |
| P2860 | cites work | Recurrence of bipolar disorders and major depression. A life-long perspective | Q79077975 |
| | Factors that affect adherence to bipolar disorder treatments: a stated-preference approach | Q80362225 |
| | Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up | Q80377909 |
| | Treatment adherence in individuals with rapid cycling bipolar disorder: results from a clinical-trial setting | Q80616198 |
| | Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders | Q81247827 |
| | Do you want chips with that? | Q86583053 |
| | Bipolar disorder and substance misuse: pathological and therapeutic implications of their comorbidity and cross-sensitisation | Q22241681 |
| | The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. | Q26864768 |
| | Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. | Q30619862 |
| | Good and poor adherence: optimal cut-point for adherence measures using administrative claims data | Q33487402 |
| | Identifying a cognitive impairment subgroup in adults with mood disorders | Q33775582 |
| | Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies | Q33857710 |
| | Increased risk for suicidal behavior in comorbid bipolar disorder and alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). | Q34037733 |
| | Family-focused treatment for caregivers of patients with bipolar disorder | Q34162710 |
| | Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol. | Q34307557 |
| | A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder | Q34522317 |
| | Treatment non-adherence in affective disorders. | Q34592227 |
| | Transition to mania during treatment of bipolar depression | Q34661431 |
| | Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology | Q34676317 |
| | Improving treatment adherence in patients with bipolar disorder and substance abuse: rationale and initial development of a novel psychosocial approach | Q34767177 |
| | Correlates of attitudes towards mood stabilizers in individuals with bipolar disorder | Q34777367 |
| | Psychosocial treatments for bipolar disorder: cost-effectiveness, mediating mechanisms, and future directions | Q34987684 |
| | The relationship of gender and gender identity to treatment adherence among individuals with bipolar disorder | Q35157526 |
| | Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study | Q35736374 |
| | The suicide prevention effect of lithium: more than 20 years of evidence-a narrative review | Q35858926 |
| | Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders | Q35862776 |
| | Use of automated medication adherence monitoring in bipolar disorder research: pitfalls, pragmatics, and possibilities | Q35906540 |
| | Using incentives to reduce substance use and other health risk behaviors among people with serious mental illness | Q35911508 |
| | A collaborative approach to the treatment alliance in bipolar disorder | Q35947326 |
| | Role of treatment alliance in the clinical management of bipolar disorder: stronger alliances prospectively predict fewer manic symptoms | Q36104578 |
| | Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis | Q36156730 |
| | Symptom severity, self-reported adherence, and electronic pill monitoring in poorly adherent patients with bipolar disorder | Q36248072 |
| | Identifying and improving non-adherence in bipolar disorders. | Q36286408 |
| | Suboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioning | Q36557235 |
| | Is antipsychotic medication stigmatizing for people with mental illness? | Q36804059 |
| | Depot antipsychotic medications in bipolar disorder: a review of the literature | Q36905876 |
| | Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder. | Q36932832 |
| | Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review | Q37111491 |
| | Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder | Q37152810 |
| | Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review | Q37248065 |
| | The association between treatment adherence and antipsychotic dose among individuals with bipolar disorder | Q37293777 |
| | Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic | Q37352409 |
| | Association between therapeutic alliance, care satisfaction, and pharmacological adherence in bipolar disorder | Q37415124 |
| | Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder | Q37424330 |
| | Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk | Q37546078 |
| | Risperidone long-acting injection: in bipolar I disorder | Q37756123 |
| | Patients' reports of the factors influencing medication adherence in bipolar disorder - an integrative review of the literature | Q37863769 |
| | Psychoeducation for relapse prevention in bipolar disorder: a systematic review of efficacy in randomized controlled trials | Q38320841 |
| | Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study | Q38381456 |
| | The effect of financial incentives on adherence to antipsychotic depot medication: does it change over time? | Q38404658 |
| | First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder | Q38448612 |
| | Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients | Q38482836 |
| | Smartphone-Based Monitoring of Objective and Subjective Data in Affective Disorders: Where Are We and Where Are We Going? Systematic Review | Q38663820 |
| | BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. | Q38826206 |
| | Managing bipolar moods without medication: a qualitative investigation. | Q39070452 |
| | Treatment-adherence in bipolar disorder: A patient-centred approach | Q39080703 |
| | Substance abuse in patients with bipolar disorder: A systematic review and meta-analysis | Q39248839 |
| | Neurocognitive functioning in bipolar depression: a component structure analysis | Q39396568 |
| | Comparative effectiveness of long-acting injectable risperidone vs. long-acting injectable first-generation antipsychotics in bipolar disorder. | Q39905437 |
| | Factors associated with treatment nonadherence among US bipolar disorder patients | Q40146888 |
| | Adherence to medication in bipolar disorder: a qualitative study exploring the role of patients' beliefs about the condition and its treatment | Q40175775 |
| | Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization | Q40623890 |
| | Lithium use and discontinuation in a health maintenance organization | Q41014056 |
| | Outcome in the pharmacologic treatment of bipolar disorder | Q41033518 |
| | Neuropsychological functioning, age, and medication adherence in bipolar disorder | Q41616576 |
| | Short-term clinical stability and lack of insight are associated with a negative attitude towards antipsychotic treatment at discharge in patients with schizophrenia and bipolar disorder | Q41788185 |
| | Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study | Q43120870 |
| | One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder. | Q43997086 |
| | Longitudinal course of cognitive deficits in bipolar disorder: a meta-analytic study | Q44043929 |
| | Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. | Q44048838 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. | Q44142664 |
| | Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study | Q44671658 |
| | Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients | Q44710965 |
| | Neurocognitive impairment in euthymic patients with bipolar affective disorder | Q45209990 |
| | Annual cost of managing bipolar disorder to the UK healthcare system | Q45337375 |
| | A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. | Q45931601 |
| | Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study | Q46074383 |
| | Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). | Q46086886 |
| | The long-term natural history of the weekly symptomatic status of bipolar I disorder | Q46317822 |
| | British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. | Q46434448 |
| | The association between moderate alcohol use and illness severity in bipolar disorder: a preliminary report | Q46903470 |
| | Comparison of treatment-emergent extrapyramidal symptoms in patients with bipolar mania or schizophrenia during olanzapine clinical trials. | Q46903473 |
| | Neurocognitive features in clinical subgroups of bipolar disorder: A meta-analysis | Q47564625 |
| | Promoting medication adherence among patients with bipolar disorder: a multicenter randomized controlled trial of a multifaceted intervention. | Q47739325 |
| | Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder | Q47833116 |
| | Paliperidone Palmitate Depot in the Long-term Treatment of Psychotic Bipolar Disorder: A Case Series. | Q48074880 |
| | The impact of cognitive impairment, neurological soft signs and subdepressive symptoms on functional outcome in bipolar disorder | Q48144555 |
| | Psychiatrists' perceptions of potential reasons for non- and partial adherence to medication: results of a survey in bipolar disorder from eight European countries | Q48637084 |
| | A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder | Q48697520 |
| | [Bipolar affective disorder: pharmacotherapeutic profile and adherence to medication]. | Q50493957 |
| | Impact of family burden and affective response on clinical outcome among patients with bipolar disorder. | Q50993460 |
| | Treatment nonadherence and neurocognitive impairment in bipolar disorder. | Q51868094 |
| | Patients' perceptions of information received about medication prescribed for bipolar disorder: implications for informed choice. | Q51908862 |
| | Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study. | Q51927598 |
| | A pilot study of concordance therapy for individuals with bipolar disorders who are non-adherent with lithium prophylaxis. | Q53660297 |
| | Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. | Q54106227 |
| | Treatment adherence in bipolar I and schizoaffective disorder, bipolar type | Q57612378 |
| | The prognostic role of perceived criticism, medication adherence and family knowledge in bipolar disorders | Q57612450 |
| | Effects of the Rate of Discontinuing Lithium Maintenance Treatment in Bipolar Disorders | Q60643067 |
| | A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder | Q73918315 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 349-363 | |
| P577 | publication date | 2018-10-16 | |
| P1433 | published in | Therapeutic advances in psychopharmacology | Q26842244 |
| P1476 | title | Medication nonadherence in bipolar disorder: a narrative review | |
| P478 | volume | 8 | |